Glucosamine Market Overview: Products, Applications and Future Scope
Glucosamine Market growth is closely linked to rising concern about joint health, particularly among aging populations. According to Polaris Market Research, the industry was valued at USD 964.51 million in 2024 and is expected to expand at a CAGR of 5.85% from 2025 to 2034. The market is estimated at USD 1,014.73 million in 2025 and is projected to reach USD 1,615.58 million by 2034. A growing preference for natural supplements over pharmaceutical options is a key enabler.
What Is Driving Demand?
Glucosamine is a naturally occurring compound found in the fluid around joints, and it plays a role in forming and repairing cartilage. Many people take it to ease joint pain and support mobility, especially those managing osteoarthritis. The rising prevalence of arthritis worldwide, along with an increase in obesity that puts added stress on joints, is expected to keep demand strong.
The global population is also aging, and age-related joint problems are becoming more common. Health-conscious consumers increasingly look for natural remedies, and glucosamine fits that preference. Its availability in capsules, tablets and powders through pharmacies, health food stores and online channels has made it easy to buy, which further supports the Glucosamine Market.
Sports, Fitness and Pet Care
Active lifestyles are creating new demand. As more people take part in sports and fitness, joint injuries are more common, and supplements are often used to aid recovery and maintain joint function.
Pet care is another fast-growing area. Pets are now treated as family members, and owners are paying closer attention to their nutritional needs. Glucosamine is well known for supporting joint health and mobility in animals, which makes it a popular ingredient in functional pet food. In August 2025, for example, Ultimate Pet Nutrition launched Mobility Renew, a veterinarian-developed soft chew for canine joint health.
Shift Toward Plant-Based Options
Glucosamine supplements have traditionally been sourced from crustaceans such as shrimp and crabs. Rising crustacean allergies and a growing vegan population have pushed manufacturers toward alternatives made from fungi and other plant sources. This shift widens access for consumers with dietary restrictions and is expected to support growth in dietary supplements and food and beverage uses.
Recent developments reflect the trend. In June 2024, DNP International introduced a vegetarian form of glucosamine. In May 2024, TSI Group’s GlucosaGreen earned certifications covering carbon footprint, sustainability, non-GMO status and vegan criteria, underscoring the focus on ethical and environmentally responsible production.
Explore The Complete Comprehensive Report Here : https://www.polarismarketresearch.com/industry-analysis/glucosamine-market
Segment Insights
The market is segmented by product, application and region.
By product, glucosamine sulfate held the largest share in 2024. It is widely used in dietary supplements and pharmaceuticals, has been extensively researched, and is a popular choice for people managing osteoarthritis symptoms. Glucosamine hydrochloride is expected to grow rapidly, supported by the increasing prevalence of osteoarthritis and its role in cartilage health. Other forms include N-acetyl glucosamine.
By application, the supplement segment dominated in 2024. The food and beverage segment is expected to grow at a rapid pace as consumers seek functional foods and drinks that offer benefits beyond basic nutrition. Adding glucosamine to these products lets manufacturers appeal to people who want to take proactive steps for joint health. The market also serves therapeutic goods and other uses.
Regional Outlook
Asia Pacific was the largest regional market in 2024. A large, health-conscious population and rising awareness of joint health are boosting demand for dietary supplements across the region.
Europe is expected to grow at a rapid pace. Osteoarthritis and other joint disorders are becoming more common there, and glucosamine is widely used as an accessible, natural way to relieve discomfort. An aging population and greater awareness of joint health issues add further momentum.
Competitive Landscape
The industry is fragmented, with many small manufacturers and distributors serving domestic markets. Major players include Alfa Chemical Group, Amway, Cargill, CELLMARK, Golden-Shell Pharmaceutical, Koyo Chemical Industry, Laboratoires Expanscience, Nutramax Laboratories Consumer Care and SimplySupplements. Many companies are working to develop products tailored to consumer preferences, which is expected to support growth.
Strategic moves are also shaping the sector. In October 2024, ITOCHU, through its subsidiary ITOCHU Chemical Frontier, acquired a 25% stake in Maypro Group, a company known for glucosamine production. In July 2025, Torrent Pharmaceuticals launched Shelcal Total, a nutrition supplement powder that combines glucosamine with calcium, vitamins and other ingredients for bone and joint support. In June 2025, TYLENOL introduced Proactive Support, a drug-free joint health supplement.
Glucosamine Market prospects remain encouraging as aging populations, active lifestyles and pet care trends continue to widen the customer base. Plant-based formulations and functional foods are likely to open fresh opportunities, while Asia Pacific retains its lead and Europe gains speed. Companies that offer high-quality, sustainable and allergen-friendly products will be best placed to benefit through 2034.
More Trending Latest Reports By Polaris Market Research:
Disinfection And Sterilization Equipment Market
Cancer or Tumor Profiling Market
Disinfection And Sterilization Equipment Market
EMEA Point-Of-Care Diagnostics Market
- Art
- Causes
- Crafts
- Dance
- Drinks
- Film
- Fitness
- Food
- Παιχνίδια
- Gardening
- Health
- Κεντρική Σελίδα
- Literature
- Music
- Networking
- άλλο
- Party
- Religion
- Shopping
- Sports
- Theater
- Wellness